CIK: 0001061768 · Show all filings
Period: Q4 2013 (← Previous) (Next →)
Filing Date: Feb 13, 2014
Total Value ($000): $3,529,353 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MU | MICRON TECHNOLOGY INC | 51,655,434 | $1,123,506 | 31.8% | $11.99 | +58.2% | COM | 595112103 |
| — | THERAVANCE INC | 20,144,301 | $718,144 | 20.3% | $38.53 | — | COM | 88338T104 |
| VSAT | VIASAT INC | 11,129,200 | $697,244 | 19.8% | $59.62 | +5.6% | COM | 92552V100 |
| BP | BP PLC | 5,666,413 | $275,444 | 7.8% | $41.82 | — | SPONSORED ADR | 055622104 |
| — | IDENIX PHARMACEUTICALS INC | 36,910,868 | $220,727 | 6.3% | $4.20 | — | COM | 45166R204 |
| — | CITIGROUP INC | 104,246,007 | $67,760 | 1.9% | $0.77 | — | *W EXP 01/04/201 | 172967226 |
| — | FIDELITY NATIONAL FINANCIAL | 1,974,400 | $64,069 | 1.8% | $32.45 | — | CL A | 31620R105 |
| — | CHIPMOS TECH BERMUDA LTD | 3,283,235 | $63,169 | 1.8% | $19.13 | — | SHS | G2110R114 |
| PBF | PBF ENERGY INC | 1,976,606 | $62,184 | 1.8% | $25.04 | +9.0% | CL A | 69318G106 |
| NG | NOVAGOLD RES INC | 21,688,300 | $55,088 | 1.6% | $2.49 | -8.9% | COM NEW | 66987E206 |
| — | SYNERON MEDICAL LTD | 4,000,000 | $49,200 | 1.4% | $8.70 | — | ORD SHS | M87245102 |
| — | ROVI CORP | 2,160,000 | $42,530 | 1.2% | $22.84 | — | COM | 779376102 |
| — | KINDRED BIOSCIENCES INC | 2,900,000 | $32,393 | 0.9% | $11.17 | — | COM | 494577109 |
| — | ALLIANCE ONE INTL INC | 6,383,641 | $19,470 | 0.6% | $3.80 | — | COM | 018772103 |
| — | AMERICAN INTL GROUP INC | 656,443 | $13,293 | 0.4% | $18.24 | — | *W EXP 01/19/202 | 026874156 |
| — | NOVACOPPER INC | 5,005,298 | $7,608 | 0.2% | $1.75 | — | COM | 66988K102 |
| — | AVEO PHARMACEUTICALS INC | 3,829,350 | $7,008 | 0.2% | $2.50 | — | COM | 053588109 |
| — | ALON USA PARTNERS LP | 329,188 | $5,484 | 0.2% | $16.66 | — | UT LTDPART INT | 02052T109 |
| ENZN | ENZON PHARMACEUTICALS INC | 4,337,858 | $5,032 | 0.1% | $0.09 | -7.0% | COM | 293904108 |